Meridian Study: Danielle Grant's case against designing for the billing month

The left-hand column holds Danielle's portrait in an arch-topped frame, her name, her role and market, the two kinds of invitation she accepts, board and speaking, and a contact link. Beneath a fine rule, in italic serif, sits her philosophy: a reading is worth asking for only when someone with the time and authority to act will look at it.

The wider column opens under a double rule in navy. An eyebrow reads From the study, then the essay's subject, Reimbursement and product design, a September 2026 date and the reading time. The title follows in large serif type, then a standfirst about codes that pay for days of readings and minutes of a nurse's time, and a bracketed [1] that leads to the full essay as a footnote would. On a phone the order reverses: the argument comes first and the portrait shrinks to a small arch beside her name.

Under the heading On the reading table, her other two essays appear as numbered references: Count the steps before the first reading, on accessibility for patients over seventy, and Decision support ends where the nurse can no longer check the reasoning, on where FDA device rules begin. With only title, subject and date shown, each title must work as a disputable claim.

Three figures follow: 118,000 patients monitored, 90 per cent of new patients sending a reading within thirty days, and 31 heart-failure alerts per 100 patients a week. An About the author panel quotes the start of her biography, a grandmother's weights written on a Toledo kitchen calendar that nobody read. Her thesis, proof points and current focus follow. A closing record, Beyond the page, shows her unpaid community health centre directorship, one trade-press article and her two nursing and informatics degrees, and her chief executive's words on the COPD pilot.

Meridian sets deep navy text on a pale blue-grey ground, with slightly darker panels, slate secondary text and grey-blue rules. A stronger blue marks the double rules, footnote numbers, eyebrows and small labels. The Study loads IBM Plex Serif for headlines, the italic marginal note, the standfirst, essay bodies and the large figures, and Jost, a geometric sans-serif, for biography paragraphs, navigation, dates and captions.

The palette reads like a clinical record rather than a consumer health app, which suits Danielle. Her audience is the quality committee chair of a device maker, a chief medical officer, a nurse executive weighing a vendor. Plex Serif at the Study's larger essay size keeps a long argument about HIPAA or FDA authorisation comfortable to read.

Her career page, headed Five roles, each a step from the bedside towards the software that serves it, gives every role a main column for company facts, mandate, outcomes, decisions in context and the reason for leaving, with a ruled margin note carrying its number, dates and employer. NOTE 1 is Ardenwick, from March 2021; NOTE 5 is a Cleveland cardiac step-down unit, from July 1997. A search partner can follow her path from bedside to product chair at a glance.

The readiness page keeps her reasoning in the main column: what she would bring to a quality committee, three judgements, including declining a manufacturer's funding on HIPAA grounds, her first year, conflicts and independence. The margin holds the committees she could join and chair, twenty-four available days and one directorship. Below a double rule sit her board exposure and governance learning, with a plain note that India's databank does not apply to her.

The design suits a leader whose standing rests on a few positions argued at length: a chief medical information officer, a device maker's head of regulatory affairs, a nurse executive who writes on staffing, a health plan's head of care management. It is a poor fit for someone without essays, because the headline falls back to the leadership headline and the reading table disappears, or for a case built on product photography: the Study shows only the portrait.